Table 1.

Clinical information of the patient samples used in this study.

Donor	Gender	Age (years)	Severity	Disease	Tissue	GEO Sample ID (GSM)
M1	Male	36	Moderate	COVID-19	BALF	GSM4339769
M2	Female	37	Moderate	COVID-19	BALF	GSM4339770
M3	Male	35	Moderate	COVID-19	BALF	GSM4339772
S1	Male	62	Severe	COVID-19	BALF	GSM4339773
S2	Male	66	Severe	COVID-19	BALF	GSM4339771
S3	Male	38	Severe	COVID-19	BALF	GSM4339774
S4	Female	65	Severe	COVID-19	BALF	GSM4475051
S5	Female	36	Severe	COVID-19	BALF	GSM4475052
S6	Male	46	Severe	COVID-19	BALF	GSM4475053
HC1	Female	38	Healthy	COVID-19	BALF	GSM4475048
HC2	Male	24	Healthy	COVID-19	BALF	GSM4475049
HC3	Male	22	Healthy	COVID-19	BALF	GSM4475050
C1A	Male	60–69	Moderate	COVID-19	PBMC	GSM4557327
C1B	Male	60–69	Severe	COVID-19	PBMC	GSM4557328
C2	Male	40–49	Moderate	COVID-19	PBMC	GSM4557329
C3	Male	60–69	Severe	COVID-19	PBMC	GSM4557330
C4	Male	30–39	Severe	COVID-19	PBMC	GSM4557331
C5	Male	50–59	Moderate	COVID-19	PBMC	GSM4557332
C7	Male	20–29	Moderate	COVID-19	PBMC	GSM4557333
H1	Female	40–49	Healthy	COVID-19	PBMC	GSM4557334
H2	Male	40–49	Healthy	COVID-19	PBMC	GSM4557335
H3	Female	30–39	Healthy	COVID-19	PBMC	GSM4557336
H4	Male	40–49	Healthy	COVID-19	PBMC	GSM4557337
H5	Male	40–49	Healthy	COVID-19	PBMC	GSM4557338
H6	Male	30–39	Healthy	COVID-19	PBMC	GSM4557339